⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

CLMT

Calumet, Inc.

Basic Materials · Specialty Chemicals

55.69USD

+1.7800 (+3.30%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1▲$010
Next quarter$0.47▲$010
Current year$0.68▲$0.4410
Next year$0.63▲$010

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$0.16$0.68+0.52 (+323.7%)
2026-03-31$-0.63$-0.41+0.22 (+35.0%)
2025-12-31$-0.46$-0.18+0.27 (+59.9%)
2025-09-30$-0.43$0.2+0.63 (+147.6%)

Wall Street coverage

91 ratings from 21 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
HC Wainwright & Co.MaintainedBuy$60 $75Sep 2, 2026
UBSMaintainedNeutral$26 $47Aug 25, 2026
Goldman SachsMaintainedNeutral$40 $45Aug 18, 2026
TD CowenMaintainedHold$34 $40Aug 12, 2026
Goldman SachsMaintainedNeutral$36 $40Jul 30, 2026
HC Wainwright & Co.MaintainedBuy$33 $60Mar 30, 2026
Goldman SachsMaintainedBuy$24 $34Mar 12, 2026
Goldman SachsMaintainedBuy$20 $24Jan 30, 2026
HC Wainwright & Co.ReiteratedBuy$33Nov 10, 2025
Goldman SachsMaintainedBuy$15 $20Oct 22, 2025
UBSMaintainedNeutral$12 $13.25Aug 12, 2025
Wells FargoMaintainedOverweight$23 $21May 14, 2025
B of A SecuritiesInitiatedBuy$15May 13, 2025
Goldman SachsMaintainedBuy$16 $14Apr 30, 2025
Wells FargoMaintainedOverweight$28 $23Apr 9, 2025
UBSUpgraded from SellNeutral$15 $12Mar 17, 2025
Wells FargoMaintainedOverweight$29 $28Mar 5, 2025
HC Wainwright & Co.ReiteratedBuy$33Mar 3, 2025
HC Wainwright & Co.ReiteratedBuy$33Feb 12, 2025
UBSDowngraded from NeutralSell$20.5 $15Feb 4, 2025
HC Wainwright & Co.MaintainedBuy$25 $33Jan 13, 2025
TD CowenMaintainedBuy$27 $26Nov 11, 2024
HC Wainwright & Co.ReiteratedBuy$25Nov 11, 2024
HC Wainwright & Co.ReiteratedBuy$25Aug 12, 2024
TD CowenMaintainedBuy$20 $18Aug 12, 2024

Insider transactions

66 filings from 18 insiders · 15 buy / 3 sell over 6m

Officers and directors of CLMT, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
NARWOLD KAREN GDirectorOther7.1k——Jul 9, 2026
RAYMOND PAUL C IIIDirectorOther7.1k——Jul 9, 2026
QUINTANA JULIO MANUELDirectorOther7.1k——Jul 9, 2026
SCHUMACHER AMY MDirectorOther7.1k——Jul 9, 2026
SAJKOWSKI DANIEL JDirectorOther7.1k——Jul 9, 2026
MAWER STEPHEN PDirectorOther13.8k——Jul 9, 2026
BOSS JOHN GDirectorOther7.1k——Jul 9, 2026
TWITCHELL KAREN ADirectorOther7.1k——Jul 9, 2026
SAJKOWSKI DANIEL JDirectorSell4.2k$36.16$153kJul 1, 2026
HERITAGE GROUPBeneficial Owner of more than 10% of a Class of SecurityGift540.0k——Jun 5, 2026
HERITAGE GROUPBeneficial Owner of more than 10% of a Class of SecurityExercise1.02M$20.00$20.40MMay 15, 2026
HERITAGE GROUPBeneficial Owner of more than 10% of a Class of SecuritySell627.0k$32.54$20.40MMay 15, 2026
SAJKOWSKI DANIEL JDirectorSell3.3k$34.46$114kApr 1, 2026
FLEMING BRUCE AOfficerOther20.6k——Mar 9, 2026
OBERMEIER SCOTTOfficerOther24.1k——Mar 9, 2026
MAWER STEPHEN PDirectorOther27.8k——Mar 9, 2026
BORGMANN LOUIS TODDChief Executive OfficerOther50.0k——Mar 9, 2026
MORICAL GREGORY JGeneral CounselOther15.3k——Mar 9, 2026
FLEMING BRUCE AOfficerGift50.0k——Dec 17, 2025
RAYMOND PAUL C IIIDirectorOther5.1k——Dec 4, 2025

Analyst Notes

Sign in to write

No analyst notes on CLMT yet.

Analyst Ratings

5 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current02400Hold2.67
1 mo ago02400Hold2.67
2 mo ago02400Hold2.67
3 mo ago02400Hold2.67
Price target$53.40$40.00 – $75.00
-4.1% to target